Virtus Investment Advisers’s BioNTech BNTX Stock Holding History

Virtus Investment Advisers’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Buy	12,844 +3,940	+44%	+$371K	0.28%	177
2026 Q1	$791K	Buy	8,904 +1,697	+24%	+$174K	0.22%	161
2025 Q4	$686K	Buy	7,207 +2,971	+70%	+$299K	0.19%	177
2025 Q3	$418K	Hold	4,236	–	–	0.12%	224
2025 Q2	$451K	Buy	4,236 +1,260	+42%	+$127K	0.15%	195
2025 Q1	$271K	Buy	+2,976	New	+$333K	0.07%	248
2023 Q1	–	Sell	-104	Closed	-$15.6K	–	282
2022 Q4	$15.6K	Hold	104	–	–	0.01%	319
2022 Q3	$14K	Buy	+104	New	+$15.9K	0.01%	373

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Virtus Investment Advisers's BNTX Position: Q2 2026 in Review

Virtus Investment Advisers increased its BioNTech (BNTX) stake by 44% in Q2 2026, buying an estimated $371K and bringing the position to 12,844 shares worth $1.2M. The position accounts for 0.28% of the portfolio, ranked #177.

Virtus Investment Advisers first reported a position in BNTX in Q3 2022 and has held it in 8 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Virtus Investment Advisers held 12,844 shares of BioNTech worth $1.2M as of Q2 2026.
Virtus Investment Advisers bought 3,940 BioNTech shares in Q2 2026, an estimated $371K.
BioNTech made up 0.28% of Virtus Investment Advisers's portfolio in Q2 2026, its #177 holding.
Virtus Investment Advisers first reported a position in BioNTech in Q3 2022 and has held it in 8 quarters since.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.